Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alkermes plc (ALKS)

  • Event
  • July 27, 2022, 11:05 UTC
  • 13
  • 1 comments

(30% Negative) Alkermes plc. (ALKS) Reports Q3 2022 Financial Results

Comment Full text

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • July 27, 2022, 11:03 UTC
  • 10
  • 1 comments

(10% Negative) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Regulatory Update (Form 6-K)

Comment Full text

BioNTech SE (BNTX)

  • Event
  • July 27, 2022, 10:55 UTC
  • 10
  • 1 comments

(75% Positive) BioNTech SE (BNTX) Announces Regulatory Update (Form 6-K)

Comment Full text

United Therapeutics (UTHR)

  • Event
  • July 27, 2022, 03:04 UTC
  • 87
  • 0 comments

United Therapeutics - United Therapeutics Second Quarter 2022 Financial Results

Comment Full text

Alkermes plc (ALKS)

  • Event
  • July 27, 2022, 00:00 UTC
  • 22
  • 1 comments

(76% Positive) Alkermes plc. (ALKS) Reports 70% Loss Reduction for 2022-06-30

Comment Full text

Scholar Rock Holding Corp (SRRK)

  • Event
  • July 26, 2022, 21:01 UTC
  • 13
  • 1 comments

(96% Neutral) Scholar Rock Holding Corporation (SRRK) Provides Update on experience for our first potenti

Comment Full text

Supernus Pharmaceuticals Inc (SUPN)

  • Event
  • July 26, 2022, 20:42 UTC
  • 13
  • 1 comments

(99% Neutral) Supernus Pharmaceuticals Inc (SUPN) Files Form 8-K

Comment Full text

Summit Plc (SMMT)

  • Event
  • July 26, 2022, 20:31 UTC
  • 13
  • 1 comments

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Clinical Trial Timeline Adjustment

Comment Full text

Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS)

  • Event
  • July 26, 2022, 20:25 UTC
  • 13
  • 1 comments

(99% Neutral) Akouos, Inc. (AKUS) Announces New Board Appointment

Comment Full text

Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada) (RXDX)

  • Event
  • July 26, 2022, 20:05 UTC
  • 12
  • 1 comments

(10% Negative) PROMETHEUS BIOSCIENCES, INC. (RXDX) Announces Clinical Trial Timeline Adjustment

Comment Full text
  • Previous
  • 149
  • 150
  • 151
  • 152
  • 153
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124508)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin